← FDA Drug Approvals (Drugs@FDA)

LAMICTAL XR

NDA · New Drug Application · Sponsor: SMITHKLINE BEECHAM · Approved 2010-01-29

Drug application

FDA Application #

NDA022509

Application type

New Drug Application

Brand name

LAMICTAL XR

Generic name

Lamotrigine

Active ingredients

LAMOTRIGINE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

SMITHKLINE BEECHAM

First approval

2010-01-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown